Biofrontera (BFRI)

• Market cap: $10.6M
• 1 day: 11.88%
• 5 days: 18.95%
• 1 month: 18.69%
• 3 months: 4.63%
• 6 months: 42.12%
• Year to date: 3.67%
• 1 year: 17.1%
• 5 years: -98.72%
• 10 years: -98.72%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Employees: 93